ArticleCancers2021

A Novel off-the-Shelf Trastuzumab-Armed NK Cell Therapy (ACE1702) Using Antibody-Cell-Conjugation Technology.

Hao-Kang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.